✦ LIBER ✦

Thiethylperazine-induced parkinsonism: in vivo demonstration of dopamine D2 receptors blockade

✍ Scribed by C. Briani; A. Cagnin; F. Chierichetti; M. Tiberio; L. Battistin; G. Pizzolato

Book ID: 111064116
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 92 KB
Volume: 11
Category: Article
ISSN: 1351-5101
DOI: 10.1111/j.1468-1331.2004.00844.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vivo PET studies of the dopamine D2 r

In vivo PET studies of the dopamine D2 receptors in rhesus monkeys with long-term MPTP-induced parkinsonism

✍ Doris J. Doudet; James E. Holden; Salma Jivan; E. Mcgeer; Richard J. Wyatt 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB 👁 2 views

Regulation by D2 Dopamine Receptors of i

Regulation by D2 Dopamine Receptors of in Vivo Dopamine Synthesis in Striata of Rats and Mice with Experimental Parkinsonism

✍ Matthew G. Richard; James P. Bennett Jr. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 415 KB

In vivo occupancy of D2 dopamine recepto

In vivo occupancy of D2 dopamine receptors by Nafadotride

✍ Beth Levant; Nichole R. Vansell 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 516 KB

Clozapine can induce high dopamine D2rec

Clozapine can induce high dopamine D2receptor occupancy in vivo

✍ Tetsuya Suhara; Takashi Okauchi; Yasuhiko Sudo; Akihiro Takano; Koichi Kawabe; J 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 89 KB

Blockade of both D-1 and D-2 dopamine re

Blockade of both D-1 and D-2 dopamine receptors may induce catalepsy in mice

✍ Zarrindast, M.R.; Habibi-Moini, S. 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 330 KB

PET demonstrates different behaviour of

PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson's disease

✍ Dr. J. O. Rinne; A. Laihinen; K. Någren; J. Bergman; O. Solin; M. Haaparanta; U. 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 609 KB

Striatal dopamine D-1 receptor binding was investigated in vivo with positron emission tomography (PET) in five patients with early Parkinson's disease using ["CI-SCH 23390. All patients had predominantly unilateral symptoms and showed a significant reduction in the accumulation of ["F]-6-F-DOPA in